Clinical Trial Update: Mitomycin C in Patients With Incurable p16 Positive Oropharyngeal and p16 Negative Head and Neck Squamous Cell Carcinoma (HNSCC) Resistant to Standard Therapies [Phase 2]

View source ↗

Summary

Phase 2 trial of mitomycin C in patients with incurable head and neck squamous cell carcinoma (p16-positive and p16-negative) resistant to standard therapies ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Mitomycin-C (mitomycin C)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Squamous Cell Carcinoma of the Head and Neck, Squamous Cell Carcinoma, Head and Neck | Phase 2 | Status: COMPLETED | Results posted: 2023-05-18